We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel: Amgen’s Aranesp OK for Non-Dialysis Patients
FDA Panel: Amgen’s Aranesp OK for Non-Dialysis Patients
October 22, 2010
An FDA advisory committee has voted overwhelmingly to recommend keeping Amgen’s Aranesp available to treat anemia associated with chronic renal failure in patients not on dialysis.